LINDSEY HENDERSON DREVECKY: Open Payments
NPI 1609215151 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 21 payments from 8 companies in 2025. Trend: 2023 $482 · 2024 $746 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $138 |
| Astellas Pharma US Inc | 3 | $71 |
| PFIZER INC. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: QULIPTA, Veozah, ELIQUIS, UBRELVY, TRELEGY ELLIPTA, VOQUEZNA, CAMZYOS, Kerendia.
Industry payments across ND — which companies pay providers there.
